Akari Therapeutics PLC (AKTX)
1.36
-0.11
(-7.48%)
USD |
NASDAQ |
May 03, 16:00
1.30
-0.06
(-4.41%)
Pre-Market: 09:21
Akari Therapeutics Shares Outstanding: 7.924M for March 29, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 29, 2024 | 7.924M |
December 31, 2023 | 6.617M |
December 29, 2023 | 5.654M |
October 13, 2023 | 5.653M |
June 30, 2023 | 5.061M |
June 01, 2023 | 5.056M |
March 31, 2023 | 5.056M |
December 31, 2022 | 3.722M |
September 16, 2022 | 3.722M |
August 22, 2022 | 2.968M |
June 30, 2022 | 2.968M |
June 28, 2022 | 2.968M |
April 30, 2022 | 2.968M |
March 31, 2022 | 2.968M |
March 10, 2022 | 2.968M |
February 28, 2022 | 2.595M |
January 04, 2022 | 2.595M |
December 31, 2021 | 2.380M |
December 28, 2021 | 2.380M |
September 30, 2021 | 2.380M |
September 27, 2021 | 2.380M |
September 22, 2021 | 2.380M |
August 27, 2021 | 2.380M |
August 09, 2021 | 1.982M |
July 14, 2021 | 2.380M |
Date | Value |
---|---|
June 30, 2021 | 1.982M |
June 01, 2021 | 1.982M |
May 31, 2021 | 1.982M |
April 15, 2021 | 1.924M |
March 31, 2021 | 1.924M |
December 31, 2020 | 1.924M |
November 05, 2020 | 1.924M |
September 30, 2020 | 1.693M |
September 11, 2020 | 1.693M |
August 31, 2020 | 1.693M |
July 06, 2020 | 1.693M |
July 01, 2020 | 1.673M |
June 30, 2020 | 1.693M |
March 31, 2020 | 1.436M |
March 15, 2020 | 1.436M |
March 04, 2020 | 1.436M |
March 03, 2020 | 1.436M |
February 19, 2020 | 1.339M |
January 31, 2020 | 1.155M |
December 31, 2019 | 1.123M |
October 11, 2019 | 1.050M |
September 30, 2019 | 1.050M |
August 28, 2019 | 1.020M |
July 31, 2019 | 0.9438M |
July 03, 2019 | 0.9438M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
0.8253M
Minimum
Jun 28 2019
7.924M
Maximum
Mar 29 2024
2.498M
Average
1.982M
Median
May 31 2021
Shares Outstanding Benchmarks
DBV Technologies SA | 192.87M |
Cellectis SA | 71.95M |
Adaptimmune Therapeutics PLC | 246.83M |
Biodexa Pharmaceuticals Plc | 4.385M |
NuCana PLC | 2.114M |